Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Mutation topography and risk stratification of acute myeloid leukemia

PROVIDER: PRJNA749620 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR15243200_1.fastq.gz	Fastqsanger.gz
	SRR15243200_2.fastq.gz	Fastqsanger.gz
	SRR15243300_1.fastq.gz	Fastqsanger.gz
	SRR15243300_2.fastq.gz	Fastqsanger.gz
	SRR15243201_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 316

Similar Datasets

Transcriptomic landscape of adult de novo acute myeloid leukemia offers prognostic biomarkers and putative targets

Project description:Acute myeloid leukemia (AML), caused by an interplay of genetic and epigenetic alterations, is a heterogeneous hematological malignancy characterized by accumulation of proliferative clonal abnormally myeloblasts in the bone marrow and blood. Chemotherapy resistance is common, and relapses occur frequently for the majority of AML patients, indicating a strong need for better therapeutic strategies. The molecular complexity of acute myeloid leukemia (AML) presents a considerable challenge to implementation of clinical genetic testing for accurate risk stratification. Identification of better biomarkers and alternative targeted therapeutic strategies therefore remain a high priority to enable improving established stratification and guiding risk-adapted therapy decisions. RNA-sequencing offers the greatest diagnostic return, enabling identification of whole-transcriptome expression, expressed gene fusions, single nucleotide and short insertion/deletion variants, and alternative splicing information. Therefore, a total of 157 patient bone marrow samples were collected as diagnosis and subjected to RNA-seq.

2022-11-23 | GSE201492 | GEO

An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

Project description:An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

| PRJNA768862 | ENA

An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

Project description:An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

| PRJNA895072 | ENA

Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia

Project description:Nrf2 overexpression increases risk of high tumor mutation burden in acute myeloid leukemia

| PRJNA673401 | ENA

Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples

Project description:This SuperSeries is composed of the following subset Series: GSE34577: Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples (training samples) GSE34714: Routine use of microarray-based gene expression profiling to identify patients with low cytogenetic risk acute myeloid leukemia: accurate results can be obtained even with suboptimal samples. (test samples) Refer to individual Series

2012-01-04 | E-GEOD-34823 | biostudies-arrayexpress

Project description:Clonal hematopoiesis and risk of acute myeloid leukemia

| PRJNA1018576 | ENA

Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk Stratification [DAb-seq]

Project description:Mixed phenotype acute leukemia (MPAL) also known as acute leukemia of ambiguous lineage (ALAL), is characterized by leukemic blasts with both lymphoid and myeloid cell surface markers. Here, we use SC multiomic profiling on newly diagnosed MPAL samples to characterize the immunophenotypic, genetic, and transcriptional landscapes of MPAL. This profiling allows us to definitively contradict the paradigm of MPAL as a disease on a continuum with myeloid and lymphoid lineage acute leukemias, and instead identifies MPAL as a distinct, stem-like disease that, unlike other leukemias, cannot be defined by genetics alone. We further describe a stem cell gene expression signature for MPAL that can predict patient survival. These results broaden our understanding of MPAL biology and suggest a path toward novel risk stratification for MPAL. Importantly, these findings have potential to direct treatment and, hopefully, ultimately improve the prognosis of this disease.

2023-08-07 | GSE230827 | GEO

Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk Stratification [normal bone marrrow PIP-Seq]

2024-03-13 | GSE261228 | GEO

Multiomic Single Cell Sequencing Identifies Stemlike Nature of Mixed Phenotype Acute Leukemia and Provides Novel Risk Stratification [PIP-seq]

2023-08-07 | GSE232073 | GEO